XBI: SPDR Biotech ETF
About
XBI was created on 2006-01-31 by SPDR. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 7251.3m in AUM and 144 holdings. XBI tracks an equal-weighted index of US biotechnology stocks.
Current Value
$93.381 Year Return
Current Value
$93.381 Year Return
Key Details
Assets Under Management
$6.58B
Div Yield %
0.15%
P/E Ratio
-
Net Asset Value
$91.99
Expense Ratio
0.35%
1Y ETF Return
0.28%
Strategies that include XBI
Stock's related to XBI
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BEAM | 71.94% | $2.09B | -9.52% | 0.00% |
| DNLI | 68.66% | $3.50B | +33.66% | 0.00% |
| PGEN | 68.24% | $228.91M | -28.00% | 0.00% |
| NTLA | 67.00% | $1.44B | -50.35% | 0.00% |
| CRSP | 65.26% | $4.01B | -30.49% | 0.00% |
| RCKT | 64.50% | $1.20B | -39.83% | 0.00% |
| PLRX | 62.67% | $778.32M | -9.55% | 0.00% |
| ALEC | 62.02% | $377.04M | -19.46% | 0.00% |
| RXRX | 61.98% | $1.80B | -4.13% | 0.00% |
| ACLX | 61.40% | $4.74B | +69.19% | 0.00% |
| DMRC | 60.63% | $694.39M | -2.06% | 0.00% |
| PRTA | 60.33% | $756.01M | -56.52% | 0.00% |
| IDYA | 59.81% | $2.24B | -15.21% | 0.00% |
| TWST | 59.59% | $2.42B | +74.27% | 0.00% |
| CRNX | 59.52% | $5.12B | +84.27% | 0.00% |
| SNDX | 58.90% | $1.35B | +2.87% | 0.00% |
| EDIT | 58.02% | $204.72M | -75.49% | 0.00% |
| AKRO | 57.96% | $2.17B | +93.09% | 0.00% |
| ALLO | 57.70% | $444.50M | -24.82% | 0.00% |
| BPMC | 57.52% | $6.01B | +42.68% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PRT | -0.06% | $48.72M | -16.56% | 10.33% |
| PRPO | -0.15% | $9.10M | -13.65% | 0.00% |
| NOC | -0.67% | $71.54B | +4.23% | 1.60% |
| GIS | 0.75% | $34.85B | -2.91% | 3.78% |
| WM | -0.75% | $87.92B | +27.58% | 1.34% |
| WHLM | 0.79% | $17.64M | -29.34% | 0.00% |
| CMG | 0.86% | $80.02B | +33.62% | 0.00% |
| IMNN | 1.16% | $10.02M | -22.89% | 0.00% |
| UUU | -1.18% | $4.97M | -41.89% | 0.00% |
| TEM | 1.40% | $8.50B | 0.00% | 0.00% |
| CANG | 1.41% | $253.50M | +212.50% | 0.00% |
| AIFU | 1.45% | $67.49M | -83.02% | 0.00% |
| BACK | 1.57% | $1.76M | -32.90% | 0.00% |
| RNR | -1.59% | $13.74B | +23.09% | 0.58% |
| GL | 1.76% | $9.18B | -8.60% | 0.86% |
| CI | 1.85% | $89.70B | +12.57% | 1.68% |
| MSDL | 1.97% | $1.83B | +0.66% | 7.26% |
| ACGL | -2.07% | $36.00B | +16.84% | 0.00% |
| VSTA | 2.24% | $204.94M | -39.33% | 0.00% |
| IMRN | 2.45% | $10.31M | -5.04% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| TCTM | -13.47% | $8.10M | -42.99% | 0.00% |
| MCK | -12.69% | $78.15B | +35.51% | 0.42% |
| PULM | -12.02% | $19.83M | +202.98% | 0.00% |
| HUSA | -10.67% | $16.69M | -11.56% | 0.00% |
| PGR | -9.43% | $149.10B | +57.29% | 0.45% |
| COR | -9.00% | $47.48B | +21.20% | 0.86% |
| OXBR | -8.48% | $19.05M | +178.18% | 0.00% |
| CME | -7.90% | $82.76B | +9.21% | 1.98% |
| CBOE | -6.92% | $21.46B | +15.84% | 1.11% |
| MNR | -5.06% | $1.66B | -10.71% | 15.90% |
| NHTC | -4.60% | $61.83M | +0.19% | 14.81% |
| BTCT | -4.56% | $42.61M | +353.33% | 0.00% |
| LITB | -4.51% | $35.48M | -75.45% | 0.00% |
| CHD | -4.28% | $27.18B | +19.50% | 1.03% |
| STG | -3.75% | $35.67M | +7.92% | 0.00% |
| TPST | -3.57% | $37.75M | -77.59% | 0.00% |
| LMT | -2.70% | $126.40B | +18.99% | 2.36% |
| SCKT | -2.48% | $10.88M | +15.32% | 0.00% |
| ACGL | -2.07% | $36.00B | +16.84% | 0.00% |
| RNR | -1.59% | $13.74B | +23.09% | 0.58% |
ETF's related to XBI
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IBB | 90.85% | $6.66B | 0.45% |
| PTH | 89.00% | $143.31M | 0.6% |
| GNOM | 88.06% | $70.59M | 0.5% |
| PBE | 87.79% | $258.53M | 0.58% |
| FBT | 85.01% | $1.11B | 0.56% |
| ARKG | 82.78% | $1.13B | 0.75% |
| XPH | 79.90% | $157.87M | 0.35% |
| BBH | 79.31% | $397.87M | 0.35% |
| IWC | 75.88% | $933.99M | 0.6% |
| ISCG | 73.46% | $640.00M | 0.06% |
| FXH | 73.20% | $1.15B | 0.62% |
| KOMP | 72.45% | $2.09B | 0.2% |
| ESML | 72.22% | $1.90B | 0.17% |
| NUSC | 71.88% | $1.27B | 0.31% |
| SMMD | 71.85% | $1.24B | 0.15% |
| PINK | 71.36% | $161.15M | 0.5% |
| PRFZ | 69.90% | $2.65B | 0.39% |
| FHLC | 69.33% | $2.73B | 0.084% |
| VHT | 69.06% | $17.06B | 0.1% |
| SMLF | 69.02% | $1.44B | 0.15% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| SOYB | 0.17% | $27.32M | 0.22% |
| KRBN | -0.41% | $242.47M | 0.85% |
| XBIL | -0.69% | $637.70M | 0.15% |
| USCI | -0.99% | $185.47M | 1.07% |
| GSG | -1.13% | $914.42M | 0.75% |
| BOXX | -1.22% | $4.43B | 0.1949% |
| SGOV | 1.47% | $27.53B | 0.09% |
| AGZD | -1.51% | $142.76M | 0.23% |
| COMT | -1.53% | $829.06M | 0.48% |
| PDBC | 1.65% | $4.40B | 0.59% |
| CLOI | 1.86% | $715.40M | 0.4% |
| HIGH | 2.07% | $302.78M | 0.51% |
| HDRO | -2.23% | $164.26M | 0.3% |
| FMF | 2.60% | $244.61M | 0.95% |
| DBC | 2.61% | $1.39B | 0.87% |
| XHLF | 2.64% | $874.27M | 0.03% |
| TBIL | -3.04% | $4.38B | 0.15% |
| BILZ | -3.32% | $563.02M | 0.14% |
| DBMF | 3.89% | $1.02B | 0.85% |
| WEAT | -3.91% | $120.27M | 0.28% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -60.06% | $388.04M | 1.43% |
| VIXY | -40.24% | $195.31M | 0.85% |
| USDU | -31.34% | $201.97M | 0.5% |
| UUP | -28.03% | $309.25M | 0.77% |
| TAIL | -19.79% | $67.98M | 0.59% |
| CTA | -13.43% | $350.27M | 0.78% |
| EQLS | -12.05% | $76.08M | 1% |
| DBA | -11.09% | $755.88M | 0.93% |
| TPMN | -10.50% | $40.60M | 0.65% |
| KMLM | -8.44% | $353.87M | 0.9% |
| KCCA | -7.30% | $220.51M | 0.87% |
| CORN | -5.76% | $61.12M | 0.2% |
| DBO | -5.18% | $217.57M | 0.77% |
| MINT | -4.56% | $11.62B | 0.35% |
| DBE | -4.46% | $50.13M | 0.77% |
| WEAT | -3.91% | $120.27M | 0.28% |
| BILZ | -3.32% | $563.02M | 0.14% |
| TBIL | -3.04% | $4.38B | 0.15% |
| HDRO | -2.23% | $164.26M | 0.3% |
| COMT | -1.53% | $829.06M | 0.48% |
News
SeekingAlpha
While the drop has resulted in extreme underperformance versus the S&P 500, it has also resulted in the sector's weight in the S&P 500 falling dramatically.
SeekingAlpha
SPDR® S&P Biotech ETF had its worst week since 2020, but the sector remains undervalued. Read why XBI is a strong buy for patient investors.
SeekingAlpha
Discover why analysts are bullish on Arcutis Biotherapeutics after strong Q3 results, despite recent market fluctuations in biotech.
SeekingAlpha
Many investors are now assessing how a new administration will impact the economy and markets. TD Asset Management's Justin Flowerday discusses the possible market drivers going forward.
SeekingAlpha
The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.
SeekingAlpha
Healthcare companies often grab headlines for their drug innovations. But itâs notoriously difficult to handicap outcomes, and we think investors' focus should be on business fundamentals.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.